AS
Anil Sadashivrao Kamble
About Anil Sadashivrao Kamble
Data last updated:
Anil Sadashivrao Kamble is a Director at Aboli Hospital Private Limited (since 2018) and Director at Crossandra Pharma Private Limited (since 2016). The companies operate in Healthcare, Chemicals and Metals and Minerals. The 2 current companies with reported revenue have a combined latest revenue of ₹1.28 Cr; the largest is Aboli Hospital Private Limited at ₹97.2 Lakh (FY 2024). Earlier, Anil Sadashivrao Kamble was a Director at Nmdc Limited (2021–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aboli Hospital Private Limited U85320MH2018PTC304240 | Director | 16 Jan 2018 | 2018 | ₹97.2 Lakh (FY 2024) | Active |
| Crossandra Pharma Private Limited U24230MH2016PTC281931 | Director | 02 Jun 2016 | 2016 | ₹30.8 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nmdc Limited L13100TG1958GOI001674 | Director | 01 Nov 2021 | 1958 | ₹25,499 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anil Sadashivrao Kamble
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sarika Anil Kamble | 07533630 | Aboli Hospital Private Limited , Crossandra Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anil Sadashivrao Kamble
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anil Sadashivrao Kamble
Anil Sadashivrao Kamble currently holds 2 directorships: Aboli Hospital Private Limited (Director, since 16 Jan 2018, revenue ₹97.2 Lakh (FY 2024)); Crossandra Pharma Private Limited (Director, since 02 Jun 2016, revenue ₹30.8 Lakh (FY 2024)).
Anil Sadashivrao Kamble was first appointed on 02 Jun 2016 as Director at Crossandra Pharma Private Limited. The most recent appointment on record is 01 Nov 2021 at Nmdc Limited.
The 2 current companies of Anil Sadashivrao Kamble that report revenue have a combined latest revenue of ₹1.28 Cr: Aboli Hospital Private Limited ₹97.2 Lakh (FY 2024); Crossandra Pharma Private Limited ₹30.8 Lakh (FY 2024).
Anil Sadashivrao Kamble held 1 earlier board appointment: Nmdc Limited (Director, 01 Nov 2021 to 31 Oct 2024).
The current boards of Anil Sadashivrao Kamble's companies include Sarika Anil Kamble (Aboli Hospital Private Limited).